+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07127835

Study Comparing Nurse-Allergist and Allergist-Led Approaches for Penicillin Allergy Delabeling and Patient Quality of Life

Led by The University of Hong Kong · Updated on 2026-04-29

440

Participants Needed

4

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a combined nurse-allergist approach versus the traditional allergist-led approach for penicillin allergy delabeling. The study aims to assess the effectiveness and safety of these methods, their impact on patients quality of life, and differences in resource use and cost-effectiveness. This approach considers patient risk levels to improve the delabeling process while maintaining comparable success and safety. Participants will receive either a nurse-led penicillin allergy delabeling service, where nurses assess risk and collaborate with allergists for low-risk cases, or an allergist-led service handling all risk levels. These diagnostic tests help categorize patients and guide the delabeling process through two distinct study groups. During the study, participants clinical and demographic data will be collected, and their progress monitored for six months. Researchers will measure outcomes like delabeling success, health-related quality of life, antibiotic use, and immunocompetence status. The study is observational, involving patients receiving care at participating hospitals, with follow-up to evaluate initial and recurrent labeling effects and age group differences.

CONDITIONS

Brief Title

Provocation After Nurse-Directed Assessment (PANDA) Study

Research Team

E

Elaine Lee

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here